Translational Research CROs in United States
30 published
30 published CROs match Translational Research in United States.
Locations in this set include United States, China, India, United Kingdom, Australia, and Germany.
Capabilities that show up most often in this set: Biologics (Monoclonal Antibodies), Cell Therapy, Small Molecule, Antibody-Drug Conjugate (ADC), and Biologics (Other).
Matching companies
AccelevirCLIA-certified CRO specializing in ultra-sensitive molecular analytics, custom immunology assays, and integrated virology-immunology workflows for cell therapies, gene editing, and infectious disease programs.
Aliri BioanalysisBioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Beantown BiotechBoston-based CRO specializing in assay development and biochemical & cellular screening for early-stage drug discovery, from target validation through lead optimization.
BioDuro-SundiaBioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.
Cassia, LLCCassia, LLC is a San Diego-based CRO specializing in green chemo-enzymatic synthesis of stable-isotope labeled metabolites, proteins, and nucleic acids, plus LC-MS/MS RNA modification mapping services for discovery and therapeutic development.
Cellentia, Inc.Specialized contract research organization offering custom bioassays, organoid culturing, AAV and MSD assays, PBMC isolation, and patient-derived 3D tumor organoid lines for drug development and translational research.
CertaraCertara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
Champions OncologyLeading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.
ChemDivChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.
ChemPartnerGlobal preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
Crown BiosciencePreclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
Cyagen BiosciencesCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.
Cyagen BiosciencesCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.
ICON plcICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
IIT Research InstituteMidsize preclinical CRO specializing in GLP-compliant toxicology, IND-enabling safety studies, infectious disease vaccine development, and inhalation toxicology with onsite integrated laboratories and 60+ years of regulatory partnership experience.
KCAS BioLeading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.
NorthernBioMichigan-based preclinical CRO specializing in targeted drug delivery, molecular biology, and bioanalysis with three GLP-compliant facilities supporting non-GLP and GLP safety assessment studies.
PerceptiveLeading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Markdown mirror: /services/translational-research/us.md